|
The ASEAN Consultative
Committee for Standards and Quality was formed by the ASEAN Economic
Minister in 1992 with the aim of removing technical barriers to trades in
order to facilitate the implementation of the Common Effective
Preferential Tariff (CEPT) Agreement to realize the ASEAN Free Trade Area
(AFTA).
At the 4th Senior Economic
Officials Meeting (SEOM) held in Medan , Indonesia on 8-10 September 1997,
the SEOM authorized ACCSQ to involve regulatory bodies in order to achieve
its mandate of eliminating technical barrier to trade. During the 24th
ACCSQ Meeting on 3rd to 4th August 2004, the formation of
a Product Working Group on Medical Device (ACCSQ-MDPWG) was
proposed to implement specific measures on medical device under the
roadmap for healthcare integration. This is to be in-line with the
decision of the ASEAN Leaders on the establishment of the ASEAN Economic
Community (AEC) by the year 2020 and fast- track integration of the eleven
priority sectors including healthcare sector. The ACCSQ-MDPWG proposal was
approved by the SEOM I/36 held on 17-19 January 2005 in Yogyakarta ,
Indonesia. |
|
`Medical
device' means any instrument, apparatus, implement, machine,
appliance, implant, in vitro reagent or calibrator, software, material
or other similar or related article:
a)
intended by the manufacturer to be used, alone or in combination, for
human beings for one or more of the specific purpose(s) of:
| - |
diagnosis,
prevention, monitoring, treatment or alleviation of
disease, |
| - |
diagnosis,
monitoring, treatment, alleviation of or compensation for an
injury, |
| - |
investigation,
replacement, modification, or support of the anatomy or of a
physiological process, |
| - |
supporting or
sustaining life, |
| - |
control of
conception, |
| - |
disinfection of
medical devices, |
| - |
providing information
for medical or diagnostic purposes by means of in-vitro examination
of specimens derived from the human
body; |
and
b)
which does not achieve its primary intended action in or on the human body
by pharmacological, immunological or metabolic means, but which may be
assisted in its intended function by such means.
Note 1: The
definition of a device for in vitro examination includes, for example,
reagents, calibrators, sample collection and storage devices, control
materials, and related instruments or apparatus. The information provided
by such an in vitro diagnostic device may be for diagnostic, monitoring or
compatibility purposes. In some jurisdictions, some in vitro diagnostic
devices, including reagents and the like, may be covered by separate
regulations.
Note 2: Products which may be considered to be
medical devices in some jurisdictions but for which there is not yet a
harmonized approach, are:
| - |
aids for handicapped
people, |
| - |
devices for the
treatment/diagnosis of diseases and injuries in
animals, |
| - |
accessories for
medical devices (see Note 3), |
| - |
disinfection
substances, |
| - |
devices incorporating
animal and human tissues which may meet the requirements of the
above definition but are subject to different
controls. |
Note 3: Accessories
intended specifically by manufacturers to be used together with a 'parent'
medical device to enable that medical device to achieve its intended
purpose should be subject to the same GHTF procedures as apply to the
medical device itself. For example, an accessory will be classified as
though it is a medical device in its own right. This may result in the
accessory having a different classification than the 'parent'
device.
Note 4: Components to medical devices are generally
controlled through the manufacturer's quality management system and the
conformity assessment procedures for the device. In some jurisdictions,
components are included in the definition of a 'medical
device'. |